I'm looking forward to today's announcement.
This isn't the first demonstration of 'knowledge/credibility' from Dr Jolanta Airey since commencing at Cynata.
I recall Dr Airey explaining how long FDA trials can take (and that the guide has now elapsed wrt GVHD P2 FDA trial for Cynata).
"To value Cynata is almost impossible in my opinion without an audit."
Some people take the share price and multiply it by the number of shares.
Ann: Cynata announces CEO succession and Board changes, page-30
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $48.50M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 28.5¢ | 27.0¢ | $16.2K | 58.81K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4807 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 5602 | 1 |
View Market Depth
| Last trade - 15.36pm 23/05/2024 (20 minute delay) ? |
| CYP (ASX) Chart |